AA
BEAT

ALPS Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

ALPS Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,429
Closed -$372K – 1048
2017
Q4 		$372K Hold
12,429
– – ﹤0.01% 700
2017
Q3 		$410K Sell
12,429
-5,438
-30% -$188K ﹤0.01% 696
2017
Q2 		$598K Buy
17,867
+46
+0.3% +$1.37K ﹤0.01% 362
2017
Q1 		$516K Sell
17,821
-4,949
-22% -$123K ﹤0.01% 377
2016
Q4 		$509K Buy
22,770
+217
+1% +$4.24K ﹤0.01% 387
2016
Q3 		$419K Buy
+22,553
New +$425K ﹤0.01% 494

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ALPS Advisors's BEAT Position: Q1 2018 in Review

ALPS Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2018, closing a stake of 12,429 shares — an estimated $372K sold.

ALPS Advisors first reported a position in BEAT in Q3 2016 and held it in 6 quarters. The position peaked at $598K in Q2 2017. 202 funds tracked by Wall St. Rank hold BEAT as of Q1 2018.

  • ALPS Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2018 after selling out during the quarter.
  • ALPS Advisors sold 12,429 BioTelemetry, Inc. shares in Q1 2018, an estimated $372K.
  • ALPS Advisors first reported a position in BioTelemetry, Inc. in Q3 2016 and held it in 6 quarters.
  • ALPS Advisors's BioTelemetry, Inc. position peaked at $598K in Q2 2017.
  • 202 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2018.

Based on ALPS Advisors's 13F filing for Q1 2018, filed 1 May 2018.